<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35304047</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">0968-0004</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>47</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Trends in biochemical sciences</Title>
          <ISOAbbreviation>Trends Biochem Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Integrating adipocyte insulin signaling and metabolism in the multi-omics era.</ArticleTitle>
        <Pagination>
          <StartPage>531</StartPage>
          <EndPage>546</EndPage>
          <MedlinePgn>531-546</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.tibs.2022.02.009</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0968-0004(22)00050-0</ELocationID>
        <Abstract>
          <AbstractText>Insulin stimulates glucose uptake into adipocytes via mTORC2/AKT signaling and GLUT4 translocation and directs glucose carbons into glycolysis, glycerol for TAG synthesis, and de novo lipogenesis. Adipocyte insulin resistance is an early indicator of type 2 diabetes in obesity, a worldwide health crisis. Thus, understanding the interplay between insulin signaling and central carbon metabolism pathways that maintains adipocyte function, blood glucose levels, and metabolic homeostasis is critical. While classically viewed through the lens of individual enzyme-substrate interactions, advances in mass spectrometry are beginning to illuminate adipocyte signaling and metabolic networks on an unprecedented scale, yet this is just the tip of the iceberg. Here, we review how 'omics approaches help to elucidate adipocyte insulin action in cellular time and space.</AbstractText>
          <CopyrightInformation>Copyright © 2022 Elsevier Ltd. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Calejman</LastName>
            <ForeName>C Martinez</ForeName>
            <Initials>CM</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA; Facultad de Medicina, Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Centro de Estudios Farmacológicos y Botánicos (CEFYBO), Laboratorio de Endocrinología Molecular (LEM), Universidad de Buenos Aires, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Doxsey</LastName>
            <ForeName>W G</ForeName>
            <Initials>WG</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fazakerley</LastName>
            <ForeName>D J</ForeName>
            <Initials>DJ</Initials>
            <AffiliationInfo>
              <Affiliation>University of Cambridge Metabolic Research Laboratories, Wellcome-Medical Research Council Institute of Metabolic Science, Cambridge CB2 0QQ, UK.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guertin</LastName>
            <ForeName>D A</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA; Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA. Electronic address: David.Guertin@umassmed.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>MR/S007091/1</GrantID>
            <Acronym>MRC_</Acronym>
            <Agency>Medical Research Council</Agency>
            <Country>United Kingdom</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK127175</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK094004</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 DK116005</GrantID>
            <Acronym>DK</Acronym>
            <Agency>NIDDK NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 CA196986</GrantID>
            <Acronym>CA</Acronym>
            <Agency>NCI NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>15</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Trends Biochem Sci</MedlineTA>
        <NlmUniqueID>7610674</NlmUniqueID>
        <ISSNLinking>0968-0004</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D007328">Insulin</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>IY9XDZ35W2</RegistryNumber>
          <NameOfSubstance UI="D005947">Glucose</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D017667" MajorTopicYN="N">Adipocytes</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005947" MajorTopicYN="N">Glucose</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007328" MajorTopicYN="Y">Insulin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">glucose</Keyword>
        <Keyword MajorTopicYN="N">insulin</Keyword>
        <Keyword MajorTopicYN="N">metabolism</Keyword>
        <Keyword MajorTopicYN="N">metabolomics</Keyword>
        <Keyword MajorTopicYN="N">phosphoproteomics</Keyword>
        <Keyword MajorTopicYN="N">white and brown adipose tissue</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of interests The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>10</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2022</Year>
          <Month>12</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>19</Day>
          <Hour>5</Hour>
          <Minute>28</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35304047</ArticleId>
        <ArticleId IdType="mid">NIHMS1794152</ArticleId>
        <ArticleId IdType="pmc">PMC9109456</ArticleId>
        <ArticleId IdType="doi">10.1016/j.tibs.2022.02.009</ArticleId>
        <ArticleId IdType="pii">S0968-0004(22)00050-0</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Mann JP and Savage DB (2019) What lipodystrophies teach us about the metabolic syndrome. J. Clin. Invest
129, 4009–4021</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6763226</ArticleId>
            <ArticleId IdType="pubmed">31380809</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fazakerley DJ
et al. (2019) Muscle and adipose tissue insulin resistance: malady without mechanism?
J. Lipid Res
60, 1720–1732</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6795081</ArticleId>
            <ArticleId IdType="pubmed">30054342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Czech MP (2017) Insulin action and resistance in obesity and type 2 diabetes. Nat. Med
23, 804–814</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6048953</ArticleId>
            <ArticleId IdType="pubmed">28697184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herman MA
et al. (2012) A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature
484, 333–338</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3341994</ArticleId>
            <ArticleId IdType="pubmed">22466288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poungvarin N
et al. (2015) Genome-Wide Analysis of ChREBP Binding Sites on Male Mouse Liver and White Adipose Chromatin. Endocrinology
156, 1982–1994</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4430618</ArticleId>
            <ArticleId IdType="pubmed">25751637</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saxton RA and Sabatini DM (2017) mTOR Signaling in Growth, Metabolism, and Disease. Cell
168, 960–976</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5394987</ArticleId>
            <ArticleId IdType="pubmed">28283069</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sundaresan NR
et al. (2011) The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sci. Signal
4, ra46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21775285</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shi J
et al. (2012) Diverse regulation of AKT and GSK-3β by O-GlcNAcylation in various types of cells. FEBS Lett
586, 2443–2450</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3407308</ArticleId>
            <ArticleId IdType="pubmed">22687243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ren W
et al. (2015) Glut4 palmitoylation at Cys223 plays a critical role in Glut4 membrane trafficking. Biochem. Biophys. Res. Commun
460,</Citation>
        </Reference>
        <Reference>
          <Citation>Humphrey SJ
et al. (2013) Dynamic adipocyte phosphoproteome reveals that Akt directly regulates mTORC2. Cell Metab
17, 1009–1020</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3690479</ArticleId>
            <ArticleId IdType="pubmed">23684622</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kreuzer J
et al. (2019) Multiplexed quantitative phosphoproteomics of cell line and tissue samples. Methods Enzymol
626, 41–65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31606085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Humphrey SJ
et al. (2018) High-throughput and high-sensitivity phosphoproteomics with the EasyPhos platform. Nat. Protoc
13, 1897–1916</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30190555</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ong S-E and Mann M (2006) A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC). Nat. Protoc
1, 2650–2660</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17406521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Needham EJ
et al. (2019) Illuminating the dark phosphoproteome. Sci. Signal
12,</Citation>
        </Reference>
        <Reference>
          <Citation>Su Z
et al. (2019) Global redox proteome and phosphoproteome analysis reveals redox switch in Akt. Nat. Commun
10, 5486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6889415</ArticleId>
            <ArticleId IdType="pubmed">31792197</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Entwisle SW
et al. (2020) Proteome and Phosphoproteome Analysis of Brown Adipocytes Reveals That RICTOR Loss Dampens Global Insulin/AKT Signaling. Mol. Cell. Proteomics
19, 1104–1119</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7338085</ArticleId>
            <ArticleId IdType="pubmed">32234964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinez Calejman C
et al. (2020) mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis. Nat. Commun
11, 575.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6989638</ArticleId>
            <ArticleId IdType="pubmed">31996678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Domanova W
et al. (2016) Unraveling Kinase Activation Dynamics Using Kinase-Substrate Relationships from Temporal Large-Scale Phosphoproteomics Studies. PLoS One
11, e0157763.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4918924</ArticleId>
            <ArticleId IdType="pubmed">27336693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee PL
et al. (2017) The Complex Roles of Mechanistic Target of Rapamycin in Adipocytes and Beyond. Trends Endocrinol. Metab
28, 319–339</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5682923</ArticleId>
            <ArticleId IdType="pubmed">28237819</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vincent EE
et al. (2011) Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer. Br. J. Cancer
104, 1755–1761</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3111153</ArticleId>
            <ArticleId IdType="pubmed">21505451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang G
et al. (2015) A Positive Feedback Loop between Akt and mTORC2 via SIN1 Phosphorylation. Cell Rep
12, 937–943</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26235620</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dibble CC
et al. (2009) Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol. Cell. Biol
29, 5657–5670</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2772744</ArticleId>
            <ArticleId IdType="pubmed">19720745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan S-X
et al. (2012) Amplification and demultiplexing in insulin-regulated Akt protein kinase pathway in adipocytes. J. Biol. Chem
287, 6128–6138</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3307283</ArticleId>
            <ArticleId IdType="pubmed">22207758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kearney AL
et al. (2021) Akt phosphorylates insulin receptor substrate to limit PI3K-mediated PIP3 synthesis. Elife
10,</Citation>
        </Reference>
        <Reference>
          <Citation>Jung SM
et al. (2019) Non-canonical mTORC2 Signaling Regulates Brown Adipocyte Lipid Catabolism through SIRT6-FoxO1. Mol. Cell
75, 807–822.e8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7388077</ArticleId>
            <ArticleId IdType="pubmed">31442424</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hsiao W-Y
et al. (2020) The Lipid Handling Capacity of Subcutaneous Fat Is Programmed by mTORC2 during Development. Cell Rep
33, 108223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7607535</ArticleId>
            <ArticleId IdType="pubmed">33027655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tang Y
et al. (2016) Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism. Nat. Commun
7, 11365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4844681</ArticleId>
            <ArticleId IdType="pubmed">27098609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hung C-M
et al. (2014) Rictor/mTORC2 loss in the Myf5 lineage reprograms brown fat metabolism and protects mice against obesity and metabolic disease. Cell Rep
8, 256–271</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4096327</ArticleId>
            <ArticleId IdType="pubmed">25001283</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kumar A
et al. (2010) Fat cell-specific ablation of rictor in mice impairs insulin-regulated fat cell and whole-body glucose and lipid metabolism. Diabetes
59, 1397–1406</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2874700</ArticleId>
            <ArticleId IdType="pubmed">20332342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung SM
et al. (2019) Brown Adipose Tissue Development and Metabolism. Handb. Exp. Pharmacol
251, 3–36</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7330484</ArticleId>
            <ArticleId IdType="pubmed">30203328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez-Gurmaches J
et al. (2018) Brown Fat AKT2 Is a Cold-Induced Kinase that Stimulates ChREBP-Mediated De Novo Lipogenesis to Optimize Fuel Storage and Thermogenesis. Cell Metab
27, 195–209.e6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5762420</ArticleId>
            <ArticleId IdType="pubmed">29153407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shearin AL
et al. (2016) Lack of AKT in adipocytes causes severe lipodystrophy. Mol Metab
5, 472–479</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4921941</ArticleId>
            <ArticleId IdType="pubmed">27408773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berwick DC
et al. (2002) The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes. J. Biol. Chem
277, 33895–33900</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12107176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beg M
et al. (2017) Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake. Elife
6,</Citation>
        </Reference>
        <Reference>
          <Citation>Kearney AL
et al. (2019) Serine 474 phosphorylation is essential for maximal Akt2 kinase activity in adipocytes. J. Biol. Chem
294, 16729–16739</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6851323</ArticleId>
            <ArticleId IdType="pubmed">31548312</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Betz C
et al. (2013) Feature Article: mTOR complex 2-Akt signaling at mitochondria-associated endoplasmic reticulum membranes (MAM) regulates mitochondrial physiology. Proc. Natl. Acad. Sci. U. S. A
110, 12526–12534</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3732980</ArticleId>
            <ArticleId IdType="pubmed">23852728</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou X
et al. (2020) Location-specific inhibition of Akt reveals regulation of mTORC1 activity in the nucleus. Nat. Commun
11, 6088.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7705703</ArticleId>
            <ArticleId IdType="pubmed">33257668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez-Gurmaches J and Guertin DA (2014) Adipocyte lineages: tracing back the origins of fat. Biochim. Biophys. Acta
1842, 340–351</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3805734</ArticleId>
            <ArticleId IdType="pubmed">23747579</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun W
et al. (2021) Plasticity and heterogeneity of thermogenic adipose tissue. Nat Metab
3, 751–761</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34158657</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klip A
et al. (2019) Thirty sweet years of GLUT4. J. Biol. Chem
294, 11369–11381</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6663870</ArticleId>
            <ArticleId IdType="pubmed">31175156</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Listenberger LL
et al. (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. U. S. A
100, 3077–3082</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC152249</ArticleId>
            <ArticleId IdType="pubmed">12629214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lotta LA
et al. (2017) Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance. Nat. Genet
49, 17–26</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5774584</ArticleId>
            <ArticleId IdType="pubmed">27841877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bartman CR
et al. (2021) Quantitative flux analysis in mammals. Nat Metab
3, 896–908</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34211182</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krycer JR
et al. (2017) Dynamic Metabolomics Reveals that Insulin Primes the Adipocyte for Glucose Metabolism. Cell Rep
21, 3536–3547</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29262332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quek L-E
et al. (2020) Dynamic C Flux Analysis Captures the Reorganization of Adipocyte Glucose Metabolism in Response to Insulin. iScience
23, 100855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7005519</ArticleId>
            <ArticleId IdType="pubmed">32058966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krycer JR
et al. (2020) Insulin signaling requires glucose to promote lipid anabolism in adipocytes. J. Biol. Chem
295, 13250–13266</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7504926</ArticleId>
            <ArticleId IdType="pubmed">32723868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohno S
et al. (2020) Kinetic Trans-omic Analysis Reveals Key Regulatory Mechanisms for Insulin-Regulated Glucose Metabolism in Adipocytes. iScience
23, 101479.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7479629</ArticleId>
            <ArticleId IdType="pubmed">32891058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>DiGirolamo M
et al. (1992) Lactate production in adipose tissue: a regulated function with extra-adipose implications. FASEB J
6, 2405–2412</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1563593</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krycer JR
et al. (2020) Lactate production is a prioritized feature of adipocyte metabolism. J. Biol. Chem
295, 83–98</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6952601</ArticleId>
            <ArticleId IdType="pubmed">31690627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu L
et al. (2016) Malic enzyme tracers reveal hypoxia-induced switch in adipocyte NADPH pathway usage. Nat. Chem. Biol
12, 345–352</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4891982</ArticleId>
            <ArticleId IdType="pubmed">26999781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feller DD and Feist E (1962) The conversion of leucine carbon into CO2, fatty acids and other products by adipose tissue. Biochim. Biophys. Acta
62, 40–44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">13892210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Green CR
et al. (2016) Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis. Nat. Chem. Biol
12, 15–21</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4684771</ArticleId>
            <ArticleId IdType="pubmed">26571352</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fernandez S
et al. (2019) Adipocyte ACLY Facilitates Dietary Carbohydrate Handling to Maintain Metabolic Homeostasis in Females. Cell Rep
27, 2772–2784.e6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6608748</ArticleId>
            <ArticleId IdType="pubmed">31141698</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Feller DD and Neville ED (1965) CONVERSION OF ACETATE TO LIPIDS AND CO2 BY LIVER OF RATS EXPOSED TO ACCLERATION STRESS. Am. J. Physiol
208, 892–895</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14286859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herman MA
et al. (2010) Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels. J. Biol. Chem
285, 11348–11356</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2857013</ArticleId>
            <ArticleId IdType="pubmed">20093359</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouskila M
et al. (2010) Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle. Cell Metab
12, 456–466</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">21035757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoxhaj G
et al. (2019) Direct stimulation of NADP synthesis through Akt-mediated phosphorylation of NAD kinase. Science
363, 1088–1092</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7261235</ArticleId>
            <ArticleId IdType="pubmed">30846598</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stöckli J
et al. (2019) ABHD15 regulates adipose tissue lipolysis and hepatic lipid accumulation. Mol Metab
25, 83–94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6601125</ArticleId>
            <ArticleId IdType="pubmed">31105056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krycer JR
et al. (2017) The amino acid transporter, SLC1A3, is plasma membrane-localised in adipocytes and its activity is insensitive to insulin. FEBS Lett
591, 322–330</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28032905</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bando H
et al. (2005) Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer. Clin. Cancer Res
11, 5784–5792</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16115917</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li H
et al. (2019) AKT2 phosphorylation of hexokinase 2 at T473 promotes tumorigenesis and metastasis in colon cancer cells via NF-κB, HIF1α, MMP2, and MMP9 upregulation. Cell. Signal
58, 99–110</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30877036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bertrand L
et al. (1999) Heart 6-phosphofructo-2-kinase activation by insulin results from Ser-466 and Ser-483 phosphorylation and requires 3-phosphoinositide-dependent kinase-1, but not protein kinase B. J. Biol. Chem
274, 30927–30933</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10521487</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Virtanen KA
et al. (2009) Functional brown adipose tissue in healthy adults. N. Engl. J. Med
360, 1518–1525</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19357407</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang X and Wahl R (2014) Responses of the insulin signaling pathways in the brown adipose tissue of rats following cold exposure. PLoS One
9, e99772.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4051765</ArticleId>
            <ArticleId IdType="pubmed">24915042</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung SM
et al. (2021) In vivo isotope tracing reveals the versatility of glucose as a brown adipose tissue substrate. Cell Rep
36, 109459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC8369932</ArticleId>
            <ArticleId IdType="pubmed">34320357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mills EL
et al. (2018) Accumulation of succinate controls activation of adipose tissue thermogenesis. Nature
560, 102–106</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7045287</ArticleId>
            <ArticleId IdType="pubmed">30022159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hui S
et al. (2020) Quantitative Fluxomics of Circulating Metabolites. Cell Metab
32, 676–688.e4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7544659</ArticleId>
            <ArticleId IdType="pubmed">32791100</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panic V
et al. (2020) Mitochondrial pyruvate carrier is required for optimal brown fat thermogenesis. Elife
9,</Citation>
        </Reference>
        <Reference>
          <Citation>Winther S
et al. (2018) Restricting glycolysis impairs brown adipocyte glucose and oxygen consumption. Am. J. Physiol. Endocrinol. Metab
314, E214–E223</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29118013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trayhurn P (1981) Fatty acid synthesis in mouse brown adipose tissue. The influence of environmental temperature on the proportion of whole-body fatty acid synthesis in brown adipose tissue and the liver. Biochim. Biophys. Acta
664, 549–560</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7272321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olsen JM
et al. (2014) Glucose uptake in brown fat cells is dependent on mTOR complex 2-promoted GLUT1 translocation. J. Cell Biol
207, 365–374</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4226734</ArticleId>
            <ArticleId IdType="pubmed">25385184</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao S
et al. (2016) ATP-Citrate Lyase Controls a Glucose-to-Acetate Metabolic Switch. Cell Rep
17, 1037–1052</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5175409</ArticleId>
            <ArticleId IdType="pubmed">27760311</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Potapova IA
et al. (2000) Phosphorylation of recombinant human ATP:citrate lyase by cAMP-dependent protein kinase abolishes homotropic allosteric regulation of the enzyme by citrate and increases the enzyme activity. Allosteric activation of ATP:citrate lyase by phosphorylated sugars. Biochemistry
39, 1169–1179</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10653665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Steinberg GR and Carling D (2019) AMP-activated protein kinase: the current landscape for drug development. Nat. Rev. Drug Discov
18, 527–551</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30867601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kjøbsted R
et al. (2018) AMPK in skeletal muscle function and metabolism. FASEB J
32, 1741–1777</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5945561</ArticleId>
            <ArticleId IdType="pubmed">29242278</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mottillo EP
et al.
Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function., Cell Metabolism, 24. (2016), 118–129</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5239668</ArticleId>
            <ArticleId IdType="pubmed">27411013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley SA
et al. (2014) Phosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells. Biochem. J
459, 275–287</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4052680</ArticleId>
            <ArticleId IdType="pubmed">24467442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ling NXY
et al. (2020) mTORC1 directly inhibits AMPK to promote cell proliferation under nutrient stress. Nature Metabolism
2, 41–49</Citation>
        </Reference>
        <Reference>
          <Citation>Pinkosky SL
et al. (2020) Long-chain fatty acyl-CoA esters regulate metabolism via allosteric control of AMPK β1 isoforms. Nature Metabolism
2, 873–881</Citation>
        </Reference>
        <Reference>
          <Citation>Hsu PP
et al. (2011) The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science
332, 1317–1322</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3177140</ArticleId>
            <ArticleId IdType="pubmed">21659604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu Y
et al. (2011) Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science
332, 1322–1326</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3195509</ArticleId>
            <ArticleId IdType="pubmed">21659605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dibble CC and Cantley LC (2015) Regulation of mTORC1 by PI3K signaling. Trends Cell Biol. 25, 545–555</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4734635</ArticleId>
            <ArticleId IdType="pubmed">26159692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu L
et al. (2018) AMP-Activated Protein Kinase (AMPK) Regulates Energy Metabolism through Modulating Thermogenesis in Adipose Tissue. Front. Physiol
9, 122.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5826329</ArticleId>
            <ArticleId IdType="pubmed">29515462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bijland S
et al. (2013) Role of AMP-activated protein kinase in adipose tissue metabolism and inflammation. Clin. Sci
124, 491–507</Citation>
        </Reference>
        <Reference>
          <Citation>Orozco JM
et al. (2020) Dihydroxyacetone phosphate signals glucose availability to mTORC1. Nat Metab
2, 893–901</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7995735</ArticleId>
            <ArticleId IdType="pubmed">32719541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inoki K
et al. (2006) TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth. Cell
126, 955–968</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16959574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Polak P
et al. (2008) Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab
8, 399–410</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19046571</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee PL
et al. (2016) Raptor/mTORC1 loss in adipocytes causes progressive lipodystrophy and fatty liver disease. Mol Metab
5, 422–432</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4877665</ArticleId>
            <ArticleId IdType="pubmed">27257602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peterson TR
et al. (2011) mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell
146, 408–420</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3336367</ArticleId>
            <ArticleId IdType="pubmed">21816276</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>White PJ
et al. (2021) Insulin action, type 2 diabetes, and branched-chain amino acids: A two-way street. Mol Metab </Citation>
        </Reference>
        <Reference>
          <Citation>Hicks KG
et al.
Protein-Metabolite Interactomics Reveals Novel Regulation of Carbohydrate Metabolism.</Citation>
        </Reference>
        <Reference>
          <Citation>Gao X
et al. (2019) γ−6-Phosphogluconolactone, a Byproduct of the Oxidative Pentose Phosphate Pathway, Contributes to AMPK Activation through Inhibition of PP2A. Mol. Cell
76, 857–871.e9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6925637</ArticleId>
            <ArticleId IdType="pubmed">31586547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trefely S
et al. (2015) Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling Pathway. J. Biol. Chem
290, 25834–25846</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4646237</ArticleId>
            <ArticleId IdType="pubmed">26342081</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhao S
et al. (2010) Regulation of cellular metabolism by protein lysine acetylation. Science
327, 1000–1004</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3232675</ArticleId>
            <ArticleId IdType="pubmed">20167786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nie H
et al. (2020) O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nat. Commun
11, 36.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6946671</ArticleId>
            <ArticleId IdType="pubmed">31911580</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu W
et al. (2018) Alterations of protein glycosylation in embryonic stem cells during adipogenesis. Int. J. Mol. Med
41, 293–301</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5746299</ArticleId>
            <ArticleId IdType="pubmed">29115405</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Humphrey SJ
et al. (2015) High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics. Nat. Biotechnol
33, 990–995</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26280412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoffman NJ
et al. (2015) Global Phosphoproteomic Analysis of Human Skeletal Muscle Reveals a Network of Exercise-Regulated Kinases and AMPK Substrates. Cell Metab
22, 922–935</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4635038</ArticleId>
            <ArticleId IdType="pubmed">26437602</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Christopher JA
et al. (2021) Subcellular proteomics. Nat Rev Methods Primers
1,</Citation>
        </Reference>
        <Reference>
          <Citation>Krahmer N
et al. (2018) Organellar Proteomics and Phospho-Proteomics Reveal Subcellular Reorganization in Diet-Induced Hepatic Steatosis. Dev. Cell
47, 205–221.e7</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30352176</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trefely S
et al. (2019) Subcellular metabolic pathway kinetics are revealed by correcting for artifactual post harvest metabolism. Mol Metab
30, 61–71</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6812369</ArticleId>
            <ArticleId IdType="pubmed">31767181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bäckdahl J
et al. (2021) Spatial mapping reveals human adipocyte subpopulations with distinct sensitivities to insulin. Cell Metab
33, 1869–1882.e6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">34380013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dueñas ME and Lee YJ (2021) Single-Cell Metabolomics by Mass Spectrometry Imaging. Adv. Exp. Med. Biol
1280, 69–82</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">33791975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosen ED and Spiegelman BM (2014) What we talk about when we talk about fat. Cell
156, 20–44</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3934003</ArticleId>
            <ArticleId IdType="pubmed">24439368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah RV
et al. (2014) Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC Cardiovasc. Imaging
7, 1221–1235</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4268163</ArticleId>
            <ArticleId IdType="pubmed">25440591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee M-J
et al. (2013) Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol. Aspects Med
34, 1–11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3549425</ArticleId>
            <ArticleId IdType="pubmed">23068073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanssen MJW
et al. (2015) Short-term cold acclimation improves insulin sensitivity in patients with type 2 diabetes mellitus. Nat. Med
21, 863–865</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26147760</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu J
et al. (2012) Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell
150, 366–376</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3402601</ArticleId>
            <ArticleId IdType="pubmed">22796012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ikeda K
et al. (2018) The Common and Distinct Features of Brown and Beige Adipocytes. Trends Endocrinol. Metab
29, 191–200</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5826798</ArticleId>
            <ArticleId IdType="pubmed">29366777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh AM and Dalton S (2018) What Can “Brown-ing” Do For You?
Trends Endocrinol. Metab
29, 349–359</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5937921</ArticleId>
            <ArticleId IdType="pubmed">29606342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kir S
et al. (2014) Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature
513, 100–104</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4224962</ArticleId>
            <ArticleId IdType="pubmed">25043053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patsouris D
et al. (2015) Burn Induces Browning of the Subcutaneous White Adipose Tissue in Mice and Humans. Cell Rep
13, 1538–1544</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4662886</ArticleId>
            <ArticleId IdType="pubmed">26586436</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balasuriya N
et al. (2018) Genetic code expansion and live cell imaging reveal that Thr-308 phosphorylation is irreplaceable and sufficient for Akt1 activity. J. Biol. Chem
293, 10744–10756</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6036199</ArticleId>
            <ArticleId IdType="pubmed">29773654</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alessi DR
et al. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J
15, 6541–6551</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC452479</ArticleId>
            <ArticleId IdType="pubmed">8978681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chu N
et al. (2018) Akt Kinase Activation Mechanisms Revealed Using Protein Semisynthesis. Cell
174, 897–907.e14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6139374</ArticleId>
            <ArticleId IdType="pubmed">30078705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tan S-X
et al. (2015) Selective insulin resistance in adipocytes. J. Biol. Chem
290, 11337–11348</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4416839</ArticleId>
            <ArticleId IdType="pubmed">25720492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gonzalez E
et al. (2011) Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor. Proc. Natl. Acad. Sci. U. S. A
108, 10162–10167</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3121842</ArticleId>
            <ArticleId IdType="pubmed">21646544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schenck A
et al. (2008) The endosomal protein Appl1 mediates Akt substrate specificity and cell survival in vertebrate development. Cell
133, 486–497</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18455989</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hogrebe A
et al. (2018) Benchmarking common quantification strategies for large-scale phosphoproteomics. Nat. Commun
9, 1045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5849679</ArticleId>
            <ArticleId IdType="pubmed">29535314</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jang C
et al. (2018) Metabolomics and Isotope Tracing. Cell
173, 822–837</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6034115</ArticleId>
            <ArticleId IdType="pubmed">29727671</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buescher JM
et al.
A roadmap for interpreting 13 C metabolite labeling patterns from cells., Current Opinion in Biotechnology, 34. (2015), 189–201</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4552607</ArticleId>
            <ArticleId IdType="pubmed">25731751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Balasuriya N
et al. (2020) Phosphorylation-dependent substrate selectivity of protein kinase B (AKT1). J. Biol. Chem
295, 8120–8134</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC7294097</ArticleId>
            <ArticleId IdType="pubmed">32350110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chu N
et al. (2018) Akt Kinase Activation Mechanisms Revealed Using Protein Semisynthesis. Cell
174, 897–907.e14</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6139374</ArticleId>
            <ArticleId IdType="pubmed">30078705</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Facchinetti V
et al. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J
27, 1932–1943</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2486276</ArticleId>
            <ArticleId IdType="pubmed">18566586</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
